Literature DB >> 9067064

The history of the psychopharmacology of schizophrenia.

H E Lehmann1, T A Ban.   

Abstract

OBJECTIVE: To review the historical development of the psychopharmacological treatment of schizophrenia.
METHOD: A chronological literature review of the clinical practices and theoretical models that have controlled drug treatment of schizophrenia at different times.
RESULTS: Effective treatment of schizophrenia was achieved only after the introduction of antipsychotic drugs, in the 1950s, and is still progressing.
CONCLUSION: Close collaboration between basic neuroscience and careful and informed clinical practice are likely to lead to continued progress.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9067064     DOI: 10.1177/070674379704200205

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  21 in total

Review 1.  Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.

Authors:  E Stip
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

Review 2.  Specific effects of reactive thiol drugs on mitochondrial bioenergetics.

Authors:  Iseli L Nantes; Tiago Rodrigues; Antonio C F Caires; Rodrigo L O R Cunha; Felipe S Pessoto; César H Yokomizo; Juliana C Araujo-Chaves; Priscila A Faria; Debora P Santana; Carolina G dos Santos
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

Review 3.  The "delayed onset" of antipsychotic action--an idea whose time has come and gone.

Authors:  Ofer Agid; Phillip Seeman; Shitij Kapur
Journal:  J Psychiatry Neurosci       Date:  2006-03       Impact factor: 6.186

Review 4.  Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway.

Authors:  R R Girgis; J A Javitch; J A Lieberman
Journal:  Mol Psychiatry       Date:  2008-04-15       Impact factor: 15.992

5.  Rustom Jal Vakil: his contributions to cardiology.

Authors:  Sumit Isharwal; Shubham Gupta
Journal:  Tex Heart Inst J       Date:  2006

Review 6.  The Canadian experience with risperidone for the treatment of schizophrenia: an overview.

Authors:  M Iskedjian; M Hux; G J Remington
Journal:  J Psychiatry Neurosci       Date:  1998-09       Impact factor: 6.186

Review 7.  Fifty Years of Research on Schizophrenia: The Ascendance of the Glutamatergic Synapse.

Authors:  Joseph T Coyle; W Brad Ruzicka; Darrick T Balu
Journal:  Am J Psychiatry       Date:  2020-12-01       Impact factor: 18.112

Review 8.  History of the Concept of Disconnectivity in Schizophrenia.

Authors:  Joseph T Coyle; Darrick T Balu; Matthew D Puhl; Glenn T Konopaske
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

9.  Emil Kraepelin: A pioneer of scientific understanding of psychiatry and psychopharmacology.

Authors:  Andreas Ebert; Karl-Jürgen Bär
Journal:  Indian J Psychiatry       Date:  2010-04       Impact factor: 1.759

10.  Quality of Life and Hormonal, Biochemical, and Anthropometric Profile Between Olanzapine and Risperidone Users.

Authors:  Aurigena Antunes de Araújo; Susana Barbosa Ribeiro; Ana Cely Souza Dos Santos; Telma Maria Araújo Moura Lemos; Caroline Addison Xavier Medeiros; Gerlane Coelho Bernardo Guerra; Raimundo Fernandes de Araújo Júnior; Antoni Serrano-Blanco; Maria Rubio-Valera
Journal:  Psychiatr Q       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.